StockData
Lipella Pharmaceuticals Inc. logo

Lipella Pharmaceuticals Inc. (LIPO) stock

LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 6/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.27KP/E –Yield –

Lipella Pharmaceuticals free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Lipella Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2023 was -$3.16M. For fiscal 2023 it was -$3.16M.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$3.16M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023-$727.71K–

More Lipella Pharmaceuticals figures

See a number that looks wrong?